The growth factors TGF-β and insulin-like growth factor 1 (IGF-1), released from the bone matrix, together with osteoclast and mesenchymal stem cell–produced IL-6, stimulate MM cell growth and survival (8, 9). This evidence concerns the gene IGF1 and Miyoshi myopathy.